19.10.2012
- Actavis, the Swiss generic drugmaker that Watson Pharmaceuticals is taking over, said revenue would rise to more than €2 billion ($2.6 billion) this year, driven by patent expiries...
16.10.2012
- Watson Pharmaceuticals has won U.S. antitrust approval to buy Swiss peer Actavis on the condition that it sell a number of their current and future products to two other companies...
05.10.2012
- The Federal Trade Commission asked the US Supreme Court on Thursday to take up its fight against deals between brand-name drug companies and generic firms which they say delay the...
15.08.2012
- Generic drugmaker Watson Pharmaceuticals sued the U.S. Food and Drug Administration, challenging a ruling against Watson's generic version of a big-selling diabetes drug, Actos...
30.04.2012
- Watson Pharmaceuticals posted higher-than-expected quarterly profit on Monday, as generic versions of the Lipitor cholesterol fighter and Lovenox blood thinner helped revenue soar...
25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
24.04.2012
- Watson Pharmaceuticals aims to announce an agreement to buy Actavis for around $6 billion on Wednesday, April 25th, in a deal making it one of the world's biggest suppliers of...
12.04.2012
- Watson Pharmaceuticals is on track to announce a deal to buy Actavis for around $6 billion by the end of April, creating one of the world's biggest producers of generic drugs...
